Desquinolinyl Lenvatinib CAS 796848-79-8 Ịdị ọcha>99.0% (HPLC) Ụlọ ọrụ etiti Lenvatinib Mesylate
Ruifu Chemical Supply Lenvatinib Mesylate Intermediates nwere ịdị ọcha dị elu
Lenvatinib Mesylate CAS 857890-39-2
4-Chloro-7-Methoxyquinoline-6-Carboxamide CAS 417721-36-9
Desquinolinyl Lenvatinib;1- (2-Chloro-4-Hydroxyphenyl) -3-Cyclopropylurea CAS 796848-79-8
Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate CAS 205448-65-3
Methyl 4-Amino-2-Methoxybenzoate CAS 27492-84-8
5- (Methoxymethylene) -2,2-Dimethyl-1,3-Dioxane-4,6-Dion CAS 15568-85-1
4-Amino-3-Chlorophenol CAS 17609-80-2
4-Amino-3-Chlorophenol Hydrochloride CAS 52671-64-4
Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate CAS 205448-66-4
Aha Chemical | 1- (2-Chloro-4-Hydroxyphenyl) -3-Cyclopropylurea. |
Ụdị okwu | Desquinolinyl Lenvatinib;Lenvatinib adịghị ọcha 16;Lenvatinib Desquinolinyl adịghị ọcha;Lenvatinib adịghị ọcha LFS-A;Lenvatinib Mesylate Intermediate Ⅲ;N- (2-Chloro-4-Hydroxyphenyl) -N'-Cyclopropyl-Urea |
Nọmba CAS | 796848-79-8 |
Nọmba CAT | RF-PI1972 |
Ọnọdụ Ahịa | N'ọkwa, Mpụta Ihe ruru Tọn |
Usoro ihe omimi | C10H11ClN2O2 |
Ibu molekụla | 226.66 |
Ebe esi nri | 364.6 ± 42.0 ℃ |
Njupụta | 1.43±0.10 g/cm3 |
Ụdị | Ruifu Chemical |
Ihe | Nkọwapụta |
Ọdịdị | Gbanyụọ-Ọcha ka ntụ ntụ siri ike na-acha ọbara ọbara |
Ụzọ ịdị ọcha / nyocha | > 99.0% (HPLC) |
Mmiri (KF) | <0.50% |
Ihe fọdụrụ na mgbanye | <0.20% |
Otu adịghị ọcha | <0.50% |
Mgbakọta adịghị ọcha | <1.00% |
Ọla dị arọ | <10ppm |
Spectrum infrared | Dabara na Ọdịdị |
NMR | Dabara na Ọdịdị |
Nlele ọkọlọtọ | Standardkpụrụ ụlọ ọrụ |
Ojiji | Ndị etiti Lenvatinib Mesylate (CAS: 857890-39-2) |
ngwugwu: Kalama, Aluminom foil bag, 25kg / Cardboard Drum, ma ọ bụ dị ka ndị ahịa chọrọ
Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe site na ìhè na mmiri mmiri
1- (2-Chloro-4-Hydroxyphenyl) -3-Cyclopropylurea, makwaara dị ka Desquinolinyl Lenvatinib, (CAS: 796848-79-8) bụ etiti ma ọ bụ adịghị ọcha nke Lenvatinib Mesylate (CAS: 857890-39-2).Desquinolinyl Lenvatinib bụ metabolite nke Lenvatinib Mesylate bụ onye na-egbochi ọnụ nke ọtụtụ tyrosine kinases na-anabata ya gụnyere VEGF, FGF na ndị na-anabata SCF.Lenvatinib bụ ọgwụ mgbochi ọrịa kansa maka ọgwụgwọ nke ụfọdụ ụdị ọrịa kansa thyroid, yana nwekwara ike maka ọrịa cancer ndị ọzọ.Na February 13, 2015, US FDA kwadoro ọgwụ anticancer Lenvatinib maka ọgwụgwọ ọrịa cancer thyroid.Lenvatinib bụ onye na-egbochi enzyme multi-ezubere iche, na-enwe ike igbochi VEGFR2 na VEGFR3 (vaskụla endothelial growth factor receptor).Aha ahia nke Lenvatinib bụ Lenvima.